Alexion Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (45)

View All

Latest Posts

About This Stock More About This Stock
Large Cap Biopharmaceuticals Metrics And Review: JNJ Splits Up
Article By: Rod Raynovich
Friday, November 12, 2021 2:12 PM EDT
Today JNJ announced a split of the Company separating its legacy consumer products from higher growth growing biopharmaceutical and medtech products.
In this article: AZN, BMY, GSK, LLY, PFE, RHHBY, ALXN, IBB, REGN, BIIB, CELG, GILD, VRTX, ABBV
Read
MRNA Surges To Record High On Plans To Join S&P 500
Article By: Schaeffers Research
Friday, July 16, 2021 10:34 AM EDT
Moderna stock is set to join the benchmark on July 21, replacing Alexion Pharmaceuticals.
In this article: MRNA Also: ALXN, AZN, SPX
Read
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Article By: Benzinga
Sunday, June 13, 2021 3:11 PM EDT
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in the form of approval for Biogen Inc.'s Alzheimer's drug Aduhelm.
In this article: PFE, ALXN, BIIB, VRTX, CYTR, TAK, ETON, CNTG, GLTO
Read
What A Difference A Day Makes In This Market
Video By: TheoTrade
Thursday, May 13, 2021 6:11 PM EDT
Today was opposite day in that everything that was largely bearish yesterday was bullish today, and vice versa. Crude oil and energy stocks were the only green/bullish spots in yesterday's sell-off, and were weak today.
In this video: ALL, ALXN, CME, TSLA, SPY, ABBV
Watch
Waiting For Fair Value
Article By: Yuval Taylor
Friday, March 12, 2021 12:15 AM EDT
The idea behind value investing is that you buy a stock well below its fair value, wait for it to appreciate to something close to its fair value, and then sell it.
In this article: AJG, BLK, GNW, HRB, JPM, NEM, NUE, WU, ALXN, MTEX, BHF
Read
All Posts

Latest Tweets for $ALXN

No tweets yet!

PARTNER HEADLINES